73 related articles for article (PubMed ID: 27021086)
1. Generation of Reactive Oxygen Species in Peripheral Blood Lymphocytes of Patients with Prostate Cancer.
Grekhova AK; Gorbacheva LB
Bull Exp Biol Med; 2016 Mar; 160(5):709-11. PubMed ID: 27021086
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells.
Itoh T; Terazawa R; Kojima K; Nakane K; Deguchi T; Ando M; Tsukamasa Y; Ito M; Nozawa Y
Free Radic Res; 2011 Sep; 45(9):1033-9. PubMed ID: 21682664
[TBL] [Abstract][Full Text] [Related]
3. [Comparative studies on the genotoxic activity of a new palladium (II) acidocomplex vs cisplatin in human blood lymphocytes in vitro].
Grekhova AK; Gorbacheva LB; Ivanova NA; Efimenko IA; Osipov AN
Biomed Khim; 2013; 59(1):107-14. PubMed ID: 23650729
[TBL] [Abstract][Full Text] [Related]
4. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
5. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
[TBL] [Abstract][Full Text] [Related]
8. Enhanced ROS-generation in lymphocytes from Alzheimer's patients.
Leutner S; Schindowski K; Frölich L; Maurer K; Kratzsch T; Eckert A; Müller WE
Pharmacopsychiatry; 2005 Nov; 38(6):312-5. PubMed ID: 16342003
[TBL] [Abstract][Full Text] [Related]
9. The Content of ROS in Blood Lymphocytes of Healthy Individuals, Individuals Irradiated as a Result of Chernobyl Disaster and Patients with Prostate Cancer.
Pelevina II; Aleshchenko AV; Antoshchina MM; Biryukov VA; Karpycheva AB; Karyakin OB; Krikunova LI; Ktitorova OV; Mkrtchyan LS; Nikonova MF; Oradovskaya IV; Paschenkova YG; Reva EV
Radiats Biol Radioecol; 2016 Sep; 56(5):469-474. PubMed ID: 30703305
[TBL] [Abstract][Full Text] [Related]
10. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
[TBL] [Abstract][Full Text] [Related]
11. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation.
Meeran SM; Katiyar S; Katiyar SK
Toxicol Appl Pharmacol; 2008 May; 229(1):33-43. PubMed ID: 18275980
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species.
Lee CK; Park KK; Chung AS; Chung WY
Food Chem Toxicol; 2012 Jul; 50(7):2565-74. PubMed ID: 22266358
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness of cisplatin in the treatment of disseminated cancer of the prostate].
Nogueira March JL; Ojea A; Jamardo D; Díez E; Figueiredo L
Arch Esp Urol; 1985; 38(1):28-34. PubMed ID: 4039554
[No Abstract] [Full Text] [Related]
15. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.
Kim SH; Kim KY; Yu SN; Park SK; Choi HD; Ji JH; Ahn SC
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):151-6. PubMed ID: 26522224
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells.
Antosiewicz J; Herman-Antosiewicz A; Marynowski SW; Singh SV
Cancer Res; 2006 May; 66(10):5379-86. PubMed ID: 16707465
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species in redox cancer therapy.
Tong L; Chuang CC; Wu S; Zuo L
Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of peripheral human blood lymphocytes induced by physical-chemical influences and generation of reactive oxygen species.
Tamashevski A; Slobozhanina E; Sergienko T; Bakkun A; Taras I; Medved I; Svirnovski A
Ann N Y Acad Sci; 2005 Jun; 1048():449-50. PubMed ID: 16154974
[TBL] [Abstract][Full Text] [Related]
19. Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling.
Qu Y; Oyan AM; Liu R; Hua Y; Zhang J; Hovland R; Popa M; Liu X; Brokstad KA; Simon R; Molven A; Lin B; Zhang WD; McCormack E; Kalland KH; Ke XS
Cancer Res; 2013 Dec; 73(23):7090-100. PubMed ID: 24101153
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of reactive oxygen species in cancer therapy.
Renschler MF
Eur J Cancer; 2004 Sep; 40(13):1934-40. PubMed ID: 15315800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
